首页> 外文期刊>Modern Pathology >Comparison of automated silver enhanced in situ hybridization and fluorescence in situ hybridization for evaluation of epidermal growth factor receptor status in human glioblastomas
【24h】

Comparison of automated silver enhanced in situ hybridization and fluorescence in situ hybridization for evaluation of epidermal growth factor receptor status in human glioblastomas

机译:自动银增强原位杂交与荧光原位杂交在人胶质母细胞瘤中评估表皮生长因子受体状态的比较

获取原文
           

摘要

The epidermal growth factor receptor (EGFR) is amplified in approximately 40% of glioblastomas making it a compelling molecular target for therapy. Before starting a therapy targeting the EGFR pathway, accurate determining of EGFR status is a prerequisite. We evaluated the reliability of the novel automated silver enhanced in situ hybridization for the detection of EGFR gene amplification in human glioblastomas. EGFR-amplification status was assessed in 93 cases of glioblastoma by silver enhanced in situ hybridization and compared with results of fluorescence in situ hybridization and immunohistochemistry. In a second cohort, silver enhanced in situ hybridization status was correlated with EGFR gene expression data. The EGFR gene was amplified in 25/90 tumours (28%) by silver enhanced in situ hybridization, and in 28/93 tumours (30%) by fluorescence in situ hybridization. The concordance rate for silver enhanced in situ hybridization and fluorescence in situ hybridization was 98%. Two glioblastomas were scored as being amplified by fluorescence in situ hybridization but not by silver enhanced in situ hybridization. Polymerase chain reaction-based EGFR-amplification data were highly correlated with EGFR silver enhanced in situ hybridization. Altogether, 81 of 91 cases (89%) showed positivity for EGFR expression by immunohistochemistry. Although EGFR protein over expression was associated with gene amplification (r=0.40, Pin situ hybridization. The high concordance rate of silver enhanced in situ hybridization and fluorescence in situ hybridization for the detection of EGFR amplification in paraffin-embedded glioblastomas samples demonstrates that silver enhanced in situ hybridization is a valid and attractive alternative to fluorescence in situ hybridization. Silver enhanced in situ hybridization combines the advantages of bright field microscopy with fully automated analysis in a cost-effective way thereby emphasizing its use for routine application in surgical pathology.
机译:表皮生长因子受体(EGFR)在约40%的胶质母细胞瘤中扩增,使其成为治疗的引人注目的分子靶标。在开始针对EGFR途径的治疗之前,必须先确定EGFR状态。我们评估了新型自动银增强原位杂交技术在人胶质母细胞瘤中检测EGFR基因扩增的可靠性。通过银增强原位杂交评估了93例胶质母细胞瘤的EGFR扩增状态,并将其与荧光原位杂交和免疫组织化学结果进行了比较。在第二个队列中,银增强的原位杂交状态与EGFR基因表达数据相关。银增强原位杂交在25/90个肿瘤(28%)中扩增了EGFR基因,荧光原位杂交在28/93肿瘤(30%)中扩增了EGFR基因。银增强原位杂交与荧光原位杂交的一致性为98%。两种胶质母细胞瘤被记为通过荧光原位杂交而未通过银增强原位杂交扩增。基于聚合酶链反应的EGFR扩增数据与EGFR银增强的原位杂交高度相关。通过免疫组织化学,在91例病例中,共有81例(89%)表现出EGFR表达阳性。尽管EGFR蛋白的过度表达与基因扩增有关(r = 0.40,Pin原位杂交。高一致性率的银增强了原位杂交和荧光原位杂交,用于检测石蜡包埋的成胶质细胞瘤样品中的EGFR扩增,表明银增强原位杂交是荧光原位杂交的一种有效且有吸引力的替代方法,银增强原位杂交以高成本效益的方式将明场显微镜的优势与全自动分析相结合,从而强调了其在外科病理学中的常规应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号